Yubo International Biotech Limited
YBGJ
$0.0163
-$0.0097-37.31%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.31% | -46.02% | -48.55% | -248.89% | -72.99% |
| Total Depreciation and Amortization | -29.13% | -20.09% | -3.58% | 196.30% | 471.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.10% | 118.63% | -- | -- | -168.06% |
| Change in Net Operating Assets | -121.93% | -924.90% | -174.07% | 169.25% | 127.37% |
| Cash from Operations | -5.23% | -77.93% | -141.35% | -61.97% | -59.95% |
| Capital Expenditure | -- | 167.20% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 41.95% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -- | -- | 100.00% |
| Cash from Investing | 41.95% | 574.33% | -- | -- | 306.03% |
| Total Debt Issued | 26.43% | 61.74% | 98.27% | 78.06% | 78.06% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.48% | 182.24% | -- | -- | -- |
| Cash from Financing | 9.88% | 72.95% | 148.50% | 122.56% | 118.77% |
| Foreign Exchange rate Adjustments | -50.79% | -506.27% | -884.86% | -263.97% | -242.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.47% | -256.88% | 148.31% | 109.22% | 124.28% |